Key result
Higher baseline lactate is linked to ~34% higher in-hospital mortality in cardiogenic shock on VA-ECMO.
Why the study?
Mortality remains substantial among patients with refractory cardiogenic shock supported with VA-ECMO, prompting evaluation of clinical outcomes and predictors of in-hospital mortality.
Cohort (n=100)
Answers are grounded in this paper and cite their sources.
In-hospital mortality among patients receiving VA-ECMO for refractory cardiogenic shock remained substantial at 51%, with baseline lactate and shock severity providing useful prognostic information.
Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary circulatory support in refractory cardiogenic shock, although mortality remains substantial. This study evaluated clinical outcomes and predictors of in-hospital mortality among patients receiving VA-ECMO. Materials and Methods: This retrospective observational study included 100 adults receiving VA-ECMO for refractory cardiogenic shock from January 2020 to December 2025 (6 years). Clinical characteristics, early physiological responses, complications, and survival outcomes were assessed. Multivariable logistic regression and receiver operating characteristic analysis were used to evaluate mortality prediction. Results: In-hospital mortality was 51%, while successful ECMO weaning occurred in 60% of patients. Nonsurvivors had higher baseline lactate concentrations (7.9 vs. 5.4 mmol/L), more advanced shock, and longer shock-to-ECMO intervals. Acute kidney injury occurred in 55%, major bleeding in 24%, and multiorgan failure in 28%. Mortality increased with higher baseline lactate concentrations. In the early-response model, baseline lactate was associated with mortality (adjusted OR 1.34, 95% CI 1.03–1.75). The baseline prediction model demonstrated an apparent AUC of 0.750 and a cross-validated AUC of 0.677. Conclusion: Mortality remained substantial despite VA-ECMO support. Baseline lactate and shock severity provided useful prognostic information, supporting further evaluation of integrated risk stratification models.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2026) conducted a cohort in Refractory cardiogenic shock (n=100). Venoarterial extracorporeal membrane oxygenation (VA-ECMO) and baseline lactate was evaluated on In-hospital mortality (adjusted OR 1.34, 95% CI 1.03-1.75). In patients on VA-ECMO for cardiogenic shock, in-hospital mortality was 51% and associated with higher baseline lactate.
Synapse has enriched 10 related papers. Consider them for comparative context: